China’s expanded list of drugs for centralized procurement comes with new rules

Following the nationwide expansion of China’s pilot program for centralized procurement of generics and off-patent originator drugs, Beijing is adding a second group of 33 drugs and unveiling new rules that could increase the number of winning sponsors that receive guaranteed market share. The latest batch, which brings to 58 the number of drugs included

Read the full 554 word article

User Sign In